BBHC
MIRM icon

Brown Brothers Harriman & Co’s Mirum Pharmaceuticals MIRM Stock Holding History

Brown Brothers Harriman & Co’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,499
Closed -$103K – 1406
2024
Q4 		$103K Hold
2,499
– – ﹤0.01% 711
2024
Q3 		$97.5K Hold
2,499
– – ﹤0.01% 695
2024
Q2 		$85.4K Hold
2,499
– – ﹤0.01% 683
2024
Q1 		$62.8K Buy
2,499
+1,305
+109% +$35.9K ﹤0.01% 726
2023
Q4 		$35.2K Hold
1,194
– – ﹤0.01% 766
2023
Q3 		$37.7K Hold
1,194
– – ﹤0.01% 747
2023
Q2 		$30.9K Buy
+1,194
New +$31.8K ﹤0.01% 783

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brown Brothers Harriman & Co's MIRM Position: Q1 2025 in Review

Brown Brothers Harriman & Co sold out of Mirum Pharmaceuticals (MIRM) in Q1 2025, closing a stake of 2,499 shares — an estimated $103K sold.

Brown Brothers Harriman & Co first reported a position in MIRM in Q2 2023 and held it in 7 quarters. The position peaked at $103K in Q4 2024. 214 funds tracked by Wall St. Rank hold MIRM as of Q1 2025.

  • Brown Brothers Harriman & Co reported no remaining Mirum Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 2,499 Mirum Pharmaceuticals shares in Q1 2025, an estimated $103K.
  • Brown Brothers Harriman & Co first reported a position in Mirum Pharmaceuticals in Q2 2023 and held it in 7 quarters.
  • Brown Brothers Harriman & Co's Mirum Pharmaceuticals position peaked at $103K in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2025, filed 14 May 2025.